Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ariad Pharmaceuticals, Inc.    

ARIAD PHARMACEUTICALS, INC.
Mes dernières consult.
Most popular
  Report  
 SummaryNewsCompany 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Company
ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer.The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge,... 
More about the company
Latest news on ARIAD PHARMACEUTICALS, INC
2017ARIAD PHARMACEUTICALS : Announces Submission of Marketing Authorization Applicat..
BU
2017ARIAD PHARMACEUTICALS : Enters into Definitive Agreement to Be Acquired by Taked..
PU
2017ARIAD PHARMACEUTICALS : Takeda to Acquire ARIAD Pharmaceuticals, Inc.
PU
2017ARIAD PHARMACEUTICALS : Acquisition May Not Be in the Best Interests of ARIA Sha..
PR
2017ARIAD SHAREHOLDER NOTICE : Faruqi & Faruqi, LLP Announces the Investigation of A..
PR
2017Brower Piven Commences An Investigation Into The Proposed Sale Of ARIAD Pharm..
BU
2017ARIAD PHARMACEUTICALS, INC. : Ariad Pharmaceuticals Cash Acquisition by Takeda P..
AC
2017Japan's Takeda ready for fresh acquisitions after $5.2 billion Ariad deal
RE
2017HARWOOD FEFFER LLP : Announces Investigation of ARIAD Pharmaceuticals, Inc.
PR
2017ARIAD PHARMACEUTICALS, INC. Rigrodsky & Long, P.A. Announces Investigation Of..
BU
More news
Sector news : Bio Therapeutic Drugs
02:59pGILEAD SCIENCES : GSK takes billion-dollar drug fight with Gilead to top AIDS me..
RE
08:02aLatecomer Sanofi looks to catch next wave of cancer therapies
RE
06/19Alexion Uses FDA Priority-Review Voucher for Blood Disorder
DJ
06/13Sanofi says on track to regain solid position in cancer drugs
RE
06/12GSK says vaccine business president to leave by year-end
RE
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
20173 THINGS IN BIOTECH YOU SHOULD LEARN : April 30, 2017 
2017SNIPPET ROUNDUP : Aerie Stumbles On Safety; Stada Is Sold At Last 
2017First-Quarter Deal Making Shows Glimmers Of Growth 
2017WHAT TO WATCH IN Q2 : Upcoming Healthcare Regulatory Events 
2017Roche Looks Ready To Rule Another Cancer Niche 
Managers
NameTitle
Christophe M. Bianchi Co-President
Paris Panayiotopoulos Co-President & Director
Nicholas Ventresca Chief Information Officer & Senior Vice President
Elona Kogan Director & General Counsel
Manmeet Singh Soni Director
Sector and Competitors
1st jan.Capitalization (M$)
ARIAD PHARMACEUTICALS, INC.0
GILEAD SCIENCES-1.97%89 796
VERTEX PHARMACEUTICALS3.44%38 655
REGENERON PHARMACEUTICALS-16.13%33 439
NEUROCRINE BIOSCIENCES, INC.31.87%9 196
GENMAB-6.69%9 076